Gemcitabine

13 registered clinical trials studyying Gemcitabine — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bla NCT06960577	AstraZeneca	Phase 3
Not Yet Recruiting	Sequential Intravesical Gemcitabine and Docetaxel for Rescue Therapy in BCG Unresponsive Non-muscle Invasive B NCT06374914	Dokuz Eylul University	—
Unknown	Hydroxychloroquine Combined With Gemcitabine in the Treatment of Advanced Non-small Cell Lung Cancer NCT05647330	Henan Cancer Hospital	Phase 2
Unknown	The Efficacy of Chemotherapy Combined With Immunocheckpoint Inhibitors in Advanced Biliary Malignancies NCT05487443	First People's Hospital of Hangzhou	Phase 2 / Phase 3
Unknown	Anlotinib Combined With Platinum/Gemcitabine for First Line Treatment of Advanced Urothelial Carcinoma NCT05030077	Tianjin Medical University Second Hospital	Phase 2
Recruiting	Evaluation of Concomitant Chemo-radiotherapy With Cisplatine vs Gemcitabin in Locally Advanced Cervicouterine NCT06156514	National Institute of Cancerología	Phase 3
Unknown	Study of Gemcitabine Plus Nab-paclitaxel Versus S1 Plus Nab-paclitaxel in Metastatic Adenocarcinoma of the Pan NCT03779464	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Phase 2
Unknown	GDPE/CEOPE Compared With CEOPE for Newly Diagnosed Patients With PTCL NCT03884205	Shandong Provincial Hospital	—
Unknown	Chidamide Combined With R-GDP in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma ( NCT03373019	Fudan University	Phase 2
Completed	Adjuvant Capecitabine vs Gemcitabine Plus Cisplatin in Resected Extrahepatic Cholangiocarcinoma NCT03079427	Asan Medical Center	Phase 2
Unknown	Gemcitabine as a Single Agent in the Maintenance Chemotherapy of Patients With Metastatic Breast Cancer NCT02188693	Xijing Hospital	—
Completed	Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic NCT01964430	Celgene	Phase 3
Completed	A Phase II Study of Gemcitabine With Oxaliplatin as First Line Chemotherapy in Advanced Biliary Tract Cancer NCT00504192	Soonchunhyang University Hospital	Phase 2